Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single high-fat challenge and trained innate immunity: A randomized controlled cross-over trial.
van Tuijl J, van Heck JIP, Bahrar H, Broeders W, Wijma J, Ten Have YM, Giera M, Zweers-van Essen H, Rodwell L, Joosten LAB, Netea MG, Afman LA, Bekkering S, Riksen NP. van Tuijl J, et al. Among authors: bahrar h. iScience. 2024 Oct 5;27(11):111103. doi: 10.1016/j.isci.2024.111103. eCollection 2024 Nov 15. iScience. 2024. PMID: 39493874 Free PMC article.
The Effect of Low-Dose Colchicine on the Phenotype and Function of Neutrophils and Monocytes in Patients with Chronic Coronary Artery Disease: A Double-Blind Randomized Placebo-Controlled Cross-Over Study.
Tercan H, van Broekhoven A, Bahrar H, Opstal T, Cossins BC, Rother N, Rodwell L, Bekkering S, El Messaoudi S, Riksen NP, Cornel JH. Tercan H, et al. Among authors: bahrar h. Clin Pharmacol Ther. 2024 Nov;116(5):1325-1333. doi: 10.1002/cpt.3394. Epub 2024 Aug 8. Clin Pharmacol Ther. 2024. PMID: 39115262 Clinical Trial.
Novel Proteome Targets Marking Insulin Resistance in Metabolic Syndrome.
Warmbrunn MV, Bahrar H, de Clercq NC, Koopen AM, de Groot PF, Rutten J, Joosten LAB, Kootte RS, Bouter KEC, Ter Horst KW, Hartstra AV, Serlie MJ, Soeters MR, van Raalte DH, Davids M, Levin E, Herrema H, Riksen NP, Netea MG, Groen AK, Nieuwdorp M. Warmbrunn MV, et al. Among authors: bahrar h. Nutrients. 2024 Jun 10;16(12):1822. doi: 10.3390/nu16121822. Nutrients. 2024. PMID: 38931177 Free PMC article.
MMR vaccination induces trained immunity via functional and metabolic reprogramming of γδ T cells.
Röring RJ, Debisarun PA, Botey-Bataller J, Suen TK, Bulut Ö, Kilic G, Koeken VA, Sarlea A, Bahrar H, Dijkstra H, Lemmers H, Gössling KL, Rüchel N, Ostermann PN, Müller L, Schaal H, Adams O, Borkhardt A, Ariyurek Y, de Meijer EJ, Kloet SL, Ten Oever J, Placek K, Li Y, Netea MG. Röring RJ, et al. Among authors: bahrar h. J Clin Invest. 2024 Jan 30;134(7):e170848. doi: 10.1172/JCI170848. J Clin Invest. 2024. PMID: 38290093 Free PMC article. Clinical Trial.
Sex-specific association of visceral and subcutaneous adipose tissue volumes with systemic inflammation and innate immune cells in people living with obesity.
van den Munckhof ICL, Bahrar H, Schraa K, Brand T, Ter Horst R, van der Graaf M, Dekker HM, Stienstra R, de Graaf J, Joosten LAB, Netea MG, Riksen NP, Rutten JHW. van den Munckhof ICL, et al. Among authors: bahrar h. Int J Obes (Lond). 2024 Apr;48(4):523-532. doi: 10.1038/s41366-023-01444-9. Epub 2023 Dec 22. Int J Obes (Lond). 2024. PMID: 38135702
Innate immune memory in cardiometabolic disease.
Bahrar H, Bekkering S, Stienstra R, Netea MG, Riksen NP. Bahrar H, et al. Cardiovasc Res. 2024 Feb 17;119(18):2774-2786. doi: 10.1093/cvr/cvad030. Cardiovasc Res. 2024. PMID: 36795085 Free PMC article. Review.
In vitro induction of trained immunity in adherent human monocytes.
Domínguez-Andrés J, Arts RJW, Bekkering S, Bahrar H, Blok BA, de Bree LCJ, Bruno M, Bulut Ö, Debisarun PA, Dijkstra H, Cristina Dos Santos J, Ferreira AV, Flores-Gomez D, Groh LA, Grondman I, Helder L, Jacobs C, Jacobs L, Jansen T, Kilic G, Klück V, Koeken VACM, Lemmers H, Moorlag SJCFM, Mourits VP, van Puffelen JH, Rabold K, Röring RJ, Rosati D, Tercan H, van Tuijl J, Quintin J, van Crevel R, Riksen NP, Joosten LAB, Netea MG. Domínguez-Andrés J, et al. Among authors: bahrar h. STAR Protoc. 2021 Feb 24;2(1):100365. doi: 10.1016/j.xpro.2021.100365. eCollection 2021 Mar 19. STAR Protoc. 2021. PMID: 33718890 Free PMC article.
Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.
Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Coan JP, Pearson HE, Bahrar H, Fowler TL, Bednarz BP, Saha S, Yang D, Gill PS, Lingen MW, Saloura V, Villaflor VM, Salgia R, Kimple RJ, Wheeler DL. Brand TM, et al. Among authors: bahrar h. Clin Cancer Res. 2018 Dec 1;24(23):6099. doi: 10.1158/1078-0432.CCR-18-3194. Clin Cancer Res. 2018. PMID: 30510088 No abstract available.
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Iida M, Bahrar H, Brand TM, Pearson HE, Coan JP, Orbuch RA, Flanigan BG, Swick AD, Prabakaran PJ, Lantto J, Horak ID, Kragh M, Salgia R, Kimple RJ, Wheeler DL. Iida M, et al. Among authors: bahrar h. Mol Cancer Ther. 2016 Sep;15(9):2175-86. doi: 10.1158/1535-7163.MCT-16-0012. Epub 2016 Jul 15. Mol Cancer Ther. 2016. PMID: 27422810 Free PMC article.
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.
Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Coan JP, Pearson HE, Bahrar H, Fowler TL, Bednarz BP, Saha S, Yang D, Gill PS, Lingen MW, Saloura V, Villaflor VM, Salgia R, Kimple RJ, Wheeler DL. Brand TM, et al. Among authors: bahrar h. Clin Cancer Res. 2015 Jun 1;21(11):2601-12. doi: 10.1158/1078-0432.CCR-14-2648. Epub 2015 Mar 12. Clin Cancer Res. 2015. PMID: 25767293 Free PMC article.
11 results